Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bristol-Myers Squibb (NY:BMY)

48.98 +0.96 (+2.00%)
Official Closing Price Updated: 7:00 PM EDT, Jul 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 10,834,274
Open 48.86
Bid (Size) 48.86 (10)
Ask (Size) 49.00 (1)
Prev. Close 48.02
Today's Range 48.36 - 49.12
52wk Range 41.90 - 63.33
Shares Outstanding 2,222,113,553
Dividend Yield 5.06%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Peering Into Bristol-Myers Squibb's Recent Short Interest
Via Benzinga
A Look Into Bristol-Myers Squibb Inc's Price Over Earnings
Via Benzinga

Performance

YTD
-13.8%
-13.8%
1 Month
+4.4%
+4.4%
3 Month
+0.9%
+0.9%
6 Month
-14.2%
-14.2%
1 Year
+14.0%
+14.0%

More News

Read More
Trump Tariffs Forces AstraZeneca To Bring Substantial Pharmaceutical Production To US
Via Benzinga
Topics Government
Why Replimune's Surprise Rejection Rattled Wall Street, And Cratered Its Stock
Via Investor's Business Daily
FDA Rejects Replimune's Blood Cancer Drug, Stock Sinks
Via Benzinga
Retail Chatter On BMY Doubles In 24 Hours With Drug Failing To Meet Primary Goal: Here's What Investors Are Thinking
Via Stocktwits
Bristol Myers, Pfizer To Offer Blood Thinning Drug At Discount: Retail Chatter Around BMY Jump 60% In 24 Hours
Via Stocktwits
3 Value Stocks We’re Skeptical Of
Via StockStory
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
Via Benzinga
Bristol Myers Squibb’s Supplemental New Drug Application (sNDA) for Sotyktu (deucravacitinib) for the Treatment of Adults with Active Psoriatic Arthritis Accepted for Review Across Four Regions Globally
From Bristol Myers Squibb
Via Business Wire
Bristol Myers' Drug Flunks Blood Cancer-Associated Anemia Trial
Via Benzinga
Bristol Myers Squibb Announces Topline Results from Phase 3 INDEPENDENCE Trial for Reblozyl® (luspatercept-aamt) in Adult Patients with Myelofibrosis-Associated Anemia
From Bristol Myers Squibb
Via Business Wire
Unpacking Q1 Earnings: Organon (NYSE:OGN) In The Context Of Other Branded Pharmaceuticals Stocks
Via StockStory
Topics Artificial Intelligence Intellectual Property
Bristol‑Myers Squibb, Pfizer Set To Launch Direct‑To‑Patient Eliquis At 40% Off
Via Benzinga
BRISTOL-MYERS SQUIBB CO (NYSE:BMY) - An Undervalued Stock with Strong Fundamentals
Via Chartmill
Bristol Myers Squibb and Pfizer Announce Direct-to-Patient Eliquis® (apixaban) Option
From Bristol Myers Squibb
Via Business Wire
Don’t Miss These 4 Stocks With Explosive Dividend Yields
Via MarketBeat
Topics Stocks
Is Bristol-Myers Squibb Still An Undervalued Biopharma Play?
Via Benzinga
1 Safe-and-Steady Stock with Exciting Potential and 2 to Brush Off
Via StockStory
Why Bristol-Myers Squibb (BMY) Shares Are Sliding Today
Via StockStory
Topics ETFs Intellectual Property Stocks
Top S&P500 movers in Friday's session
Via Chartmill
What's going on in today's session: S&P500 movers
Via Chartmill
Why Is Nano-Cap MiNK Therapeutics Stock Gaining Over 400% On Friday?
Via Benzinga
What's going on in today's session: S&P500 gap up and gap down stocks
Via Chartmill
Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies
Via Benzinga
Topics Government World Trade

Frequently Asked Questions

Is Bristol-Myers Squibb publicly traded?
Yes, Bristol-Myers Squibb is publicly traded.
What exchange does Bristol-Myers Squibb trade on?
Bristol-Myers Squibb trades on the New York Stock Exchange
What is the ticker symbol for Bristol-Myers Squibb?
The ticker symbol for Bristol-Myers Squibb is BMY on the New York Stock Exchange
What is the current price of Bristol-Myers Squibb?
The current price of Bristol-Myers Squibb is 48.98
When was Bristol-Myers Squibb last traded?
The last trade of Bristol-Myers Squibb was at 07/23/25 07:00 PM ET
What is the market capitalization of Bristol-Myers Squibb?
The market capitalization of Bristol-Myers Squibb is 108.84B
How many shares of Bristol-Myers Squibb are outstanding?
Bristol-Myers Squibb has 109B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.